Oglufanide Completed Phase 1 Trials for Ovarian Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00003773IM-862 in Treating Patients With Recurrent Ovarian Cancer